GeneNews Ltd.

GeneNews Ltd.

GeneNews Ltd.

Overview
Date Founded

1998

Headquarters

Building 2,2 East Beaver Creek Road,Richmond Hill, ON L4B 2N3

Type of Company

Public

Employees (Worldwide)

21

Industries

Medical Products & Equipment
IT Consulting & Services
Hospitals & Patient Services
Medical Support Services
Biotechnology

Company Description

GeneNews Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for early detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall in 1998 and is headquartered in Markham, Canada.

Executives & Employees

Executive Chairman of the Board & Chief Executive Officer

Chief Financial Officer

Chief Commercial Officer

Board of Directors

Executive Chairman of the Board & Chief Executive Officer at GeneNews Ltd.

Chief Executive Officer at Breakwater Resources Ltd.

Founder & Chief Executive Officer at Locus Analytics

Co-Founder at JTS Ventures, Inc.

Chief Financial Officer at GeneNews Ltd.

Paths to GeneNews Ltd.
Potential Connections via
Relationship Science
You
GeneNews Ltd.
Recent Transactions
Details Hidden

GeneNews Ltd. raised money in a private placement transaction

Details Hidden

GeneNews Ltd. raised money in a private placement transaction

Details Hidden

GeneNews Ltd. raised money in a private placement transaction

Clients

The University of Texas MD Anderson Cancer Center is one of the world’s most respected centers devoted exclusively to cancer patient care, research, education and prevention. It is located in central Houston in the Texas Medical Center. MD Anderson was created in 1941 as part of The University of Texas System. The institution is one of the nation’s original three comprehensive cancer centers designated by the National Cancer Act of 1971 and is one of 68 National Cancer Institute-designated comprehensive cancer centers today. U.S. News & World Report’s "Best Hospitals" survey has ranked MD Anderson as one of the nation’s top two cancer centers every year since the survey began in 1990.

Key Stats and Financials As of 2017
Market Capitalization
$11.5M
Total Enterprise Value
$23.7M
Earnings Per Share
$-0.04
Revenue
$534K
Net Profit
$-3.83M
EBITDA
$-6.07M
EBITDAMargin
-1,136.58%
Total Debt
$1.98M
Total Equity
$-3.78M
Enterprise Value Sales
44.31x
TEVNet Income
-6.19x
Debt TEV
0.08x
Three Year Compounded Annual Growth Rate Of Revenue
-39.83%
Five Year Compounded Annual Growth Rate Of Revenue
13.79%
Non-Profit Donations & Grants
Suppliers
Sphingotec GmbH Holding Companies | Hennigsdorf, BB

sphingotec GmbH develops biomarkers for diagnosis, prediction and monitoring of acute medical conditions. It also develops method for prediction, prevention, intervention of cancer, cardiovascular disease and kidney function. The company was founded by Andreas Bergmann in 2002 and is headquartered in Hennigsdorf, Germany.

Danaher Corporation Medical Support Services | Washington, DC

Danaher Corp. operates as a medical company, which designs, manufactures, and markets healthcare, environmental, and industrial equipment. It operates through the following segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research and clinical tools that scientists use to study cells and cell components in order to understand the causes of diseases; identify new therapies; and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Dental segment develops products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums, and supporting bones; as well as provide dental consumables, equipment, and services. The Environmental & Applied Solution segment engages in the development and manufacture of equipment, consumables, and software for various printing, marking, coding, design, and color management applications for global and water supply industries. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

Oncimmune Holdings Plc Biotechnology | Nottinghamshire, NG

Oncimmune Holdings Plc is an early cancer detection company that engages in the development and commercialization of its proprietary EarlyCDT platform technology. It has pioneer the development of tests based on the presence in the blood of autoantibody against specific tumor associated antigens that have the potential to detect cancer up to four years earlier than other methods of cancer detection, such as a chest X-ray, Spiral Computed Tomography or emerging technologies that do not benefit from the amplification of signal that occurs with the immune system, and can be applied to a very wide range of solid tumor types. The company was founded on October 9, 2015 and is headquartered in Nottinghamshire, the United Kingdom.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

OPKO Health, Inc. Pharmaceuticals - Wilmington, DE

OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Genomic Health, Inc. Medical Support Services - Redwood City, CA

Genomic Health, a global health company founded in August of 2000 and located in Redwood City, California, is committed to improving the quality of cancer treatment decisions through the research, development and commercialization of genomic-based clinical laboratory services. To that end, the company conducts sophisticated genomic research to develop clinically-validated molecular diagnostics which provide individualized information on response to certain types of therapy, as well as the likelihood of disease recurrence. These diagnostic technologies generate information that healthcare providers and patients can use in making treatment decisions. At Genomic Health, we developed and follow a highly specialized process that not only adheres rigorously to CAP (College of American Pathologists) standards and CLIA (Clinical Laboratory Improvement Amendments) regulations, but also incorporates numerous real-time quality checks and periodic proficiency testing designed to produce a high level of accuracy in information that we deliver to physicians and patients.